Effects of Exercise on Motivational Outcomes in Rectal Cancer Patients During and After Neoadjuvant Chemoradiation: A Phase II Randomized Controlled Trial

被引:2
|
作者
Arthuso, Fernanda Z. [1 ]
Morielli, Andria R. [1 ]
Usmani, Nawaid [2 ,3 ]
Joseph, Kurian [2 ,3 ]
Nijjar, Tirath [2 ,3 ]
Tankel, Keith [2 ,3 ]
Fairchild, Alysa [2 ,3 ]
Severin, Diane [2 ,3 ]
Boule, Normand G. [1 ]
Courneya, Kerry S. [1 ]
机构
[1] Univ Alberta, Coll Hlth Sci, Fac Kinesiol Sport & Recreat, Edmonton, AB T6G 2H9, Canada
[2] Univ Alberta, Coll Hlth Sci, Dept Oncol, Edmonton, AB, Canada
[3] Cross Canc Inst, Div Radiat Oncol, Edmonton, AB, Canada
基金
加拿大健康研究院;
关键词
Rectal Cancer; Chemoradiation Therapy; Exercise; Motivation; Theory of Planned Behavior; AEROBIC EXERCISE; UNDERSTANDING EXERCISE; RESISTANCE EXERCISE; CHEMOTHERAPY; SURVIVORS; IMPACT;
D O I
10.1016/j.soncn.2023.151419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Understanding exercise motivation in rectal cancer patients during and after neoadjuvant chemo-radiation therapy is important to improve adherence and achieve potential benefit. We report the motivational effects of exercise from the Exercise During and After Neoadjuvant Rectal Cancer Treatment trial.Data Sources: We randomized 36 rectal cancer patients to supervised high-intensity interval training during neoadjuvant chemoradiation therapy followed by unsupervised moderate-to-vigorous exercise after therapy, or usual care. Using the theory of planned behavior, we assessed motivation, perceived benefits/harms, and perceived barriers for exercise during and after therapy. Supervised exercise during neoadjuvant chemo-radiation therapy was experienced as meaningfully (d=0.33) more controllable (p=0.08, d=0.60), more enjoy-able (p=0.25, d=0.45), and less difficult (p=0.45, d=-0.38) than anticipated. Unsupervised exercise after therapy was experienced as meaningfully more enjoyable (p=0.047, d=0.50) and less difficult (p=0.43, d=-0.36), but also less controllable (p=0.14, d=-0.80) than anticipated. Common self-reported benefits of exercise both during and after neoadjuvant chemoradiation therapy were cardiovascular endurance, physical functioning, and quality of life. Common self-reported harms were exacerbation of treatment side effects. Frequently reported barriers to exercise during therapy were side effects of treatment, whereas exercise barriers after therapy were lack of motivation and lingering side effects.Conclusion: Exercise during and after therapy generally had positive effects on exercise motivation, however, perceived harms and barriers related to treatment side effects were identified.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Effects of exercise during and after neoadjuvant chemoradiation on symptom burden and quality of life in rectal cancer patients: a phase II randomized controlled trial
    Andria R. Morielli
    Normand G. Boulé
    Nawaid Usmani
    Keith Tankel
    Kurian Joseph
    Diane Severin
    Alysa Fairchild
    Tirath Nijjar
    Kerry S. Courneya
    Journal of Cancer Survivorship, 2023, 17 : 1171 - 1183
  • [2] Effects of exercise during and after neoadjuvant chemoradiation on symptom burden and quality of life in rectal cancer patients: a phase II randomized controlled trial
    Morielli, Andria R.
    Boule, Normand G.
    Usmani, Nawaid
    Tankel, Keith
    Joseph, Kurian
    Severin, Diane
    Fairchild, Alysa
    Nijjar, Tirath
    Courneya, Kerry S.
    JOURNAL OF CANCER SURVIVORSHIP, 2023, 17 (04) : 1171 - 1183
  • [3] Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial
    Morielli, Andria R.
    Usmani, Nawaid
    Boule, Normand G.
    Severin, Diane
    Tankel, Keith
    Joseph, Kurian
    Nijjar, Tirath
    Fairchild, Alysa
    Courneya, Kerry S.
    CLINICAL COLORECTAL CANCER, 2021, 20 (03) : 216 - 226
  • [4] Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial
    Morielli, Andria R.
    Usmani, Nawaid
    Boule, Normand G.
    Severin, Diane
    Tankel, Keith
    Nijjar, Tirath
    Joseph, Kurian
    Fairchild, Alysa
    Courneya, Kerry S.
    TRIALS, 2018, 19
  • [5] Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial
    Andria R. Morielli
    Nawaid Usmani
    Normand G. Boulé
    Diane Severin
    Keith Tankel
    Tirath Nijjar
    Kurian Joseph
    Alysa Fairchild
    Kerry S. Courneya
    Trials, 19
  • [6] Updated analysis of a prospective, randomized, controlled trial on the impact on clinical outcomes of fish oil supplementation during neoadjuvant chemoradiation for rectal cancer.
    Souza E Silva, Virgilio
    Reis Lima Silva, Mariane Messias
    Pastore Silva, Juliana De Aguiar
    Carvalho Brito, Angelo Borsarelli
    Gobo Silva, Maria Leticia
    Mello, Celso Lopes
    Aguiar, Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15594 - E15594
  • [7] Brazil-TNT: A Randomized Phase 2 Trial of Neoadjuvant Chemoradiation Followed by FOLFIRINOX Versus Chemoradiation for Stage II/III Rectal Cancer
    Bugano, Diogo Diniz Gomes
    Santos, Vanessa Montes
    Campos-Bragagnoli, Arinilda
    Melo, Julia Carole Medeiros
    Romagnolo, Luis Gustavo Capochin
    Neto, Osmar Barbosa
    Carvalho, Icaro Thiago
    Karassawa-Helito, Juliana
    Ortega, Cinthia D.
    Tridente, Cassia Franco
    Gerbasi, Lucas Soares
    Tustumi, Francisco
    Blasi, Poliana Bergamaschine Giovani
    de Araujo, Marleny Novaes Figueiredo
    Pandini, Rafael Vaz
    Seid, Victor Edmond
    Portilho, Ana Sarah
    Buosso, Albert
    Rolla, Fabiana
    de Paula Pinto Schettino, Guilherme
    Araujo, Sergio Eduardo Alonso
    CLINICAL COLORECTAL CANCER, 2024, 23 (03)
  • [8] Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
    Wu, Christina
    Williams, Terence M.
    Robb, Ryan
    Webb, Amy
    Wei, Lai
    Chen, Wei
    Mikhail, Sameh
    Ciombor, Kristen K.
    Cardin, Dana B.
    Timmers, Cynthia
    Krishna, Somashekar G.
    Arnold, Mark
    Harzman, Alan
    Abdel-Misih, Sherif
    Roychowdhury, Sameek
    Bekaii-Saab, Tanios
    Wuthrick, Evan
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3117 - 3125
  • [9] Outcomes and Immune Responses from INNATE: A Randomized Phase II Trial of Sotigalimab Immunotherapy during Neoadjuvant Therapy of Rectal Cancer
    Sanford, N. N.
    Elghonaimy, E.
    Kardosh, A.
    Kazmi, S.
    Pogacnik, J. S.
    Scott, A. J.
    Paluri, R. K.
    Zhang, S.
    Khatri, G.
    Diegeler, S.
    Goodyear, S.
    Kainthla, R.
    Chilakamarry, S.
    Al Mutar, S.
    Jones, A.
    Ali, F.
    Huang, E. H.
    Paulman, B.
    Van Pelt, J.
    Hamilton, C.
    Wachsmann, M.
    Gopal, P.
    Timmerman, R. D.
    Aguilera, T. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S5 - S6
  • [10] Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer
    Chapman, Brandon C.
    Hosokawa, Patrick
    Henderson, William
    Paniccia, Alessandro
    Overbey, Douglas M.
    Messersmith, Wells
    Lieu, Christopher
    Stiegmann, Greg V.
    Schulick, Richard D.
    Gajdos, Csaba
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 115 (08) : 1033 - 1044